Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

80%

4 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 4

3(60.0%)

Phase 3

1(20.0%)

Phase 2

1(20.0%)

5Total

Phase 4(3)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT04548349Phase 4Completed

Profiling the Skin Microbiome in Response to Altreno in Acne Patients

Role: collaborator

NCT05872256Phase 4Completed

A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis

Role: collaborator

NCT04119102Phase 4Recruiting

Duobrii in Combination With Biologics

Role: collaborator

NCT03910803Phase 2Unknown

Treatment of Moderate Hidradenitis Suppurativa

Role: collaborator

NCT00007631Phase 3Completed

Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer

Role: collaborator

All 5 trials loaded